Advisory Services Network’s Avenue Therapeutics ATXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-31
Closed -$88K – 3320
2021
Q2
$88K Buy
+31
New +$153K ﹤0.01% 1686

Other funds holding ATXI

Advisory Services Network's ATXI Position: Q3 2021 in Review

Advisory Services Network sold out of Avenue Therapeutics (ATXI) in Q3 2021, closing a stake of 31 shares — an estimated $88K sold.

Advisory Services Network first reported a position in ATXI in Q2 2021 and held it in 1 quarter. The position peaked at $88K in Q2 2021. 17 funds tracked by Wall St. Rank hold ATXI as of Q3 2021.

  • Advisory Services Network reported no remaining Avenue Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 31 Avenue Therapeutics shares in Q3 2021, an estimated $88K.
  • Advisory Services Network first reported a position in Avenue Therapeutics in Q2 2021 and held it in 1 quarter.
  • Advisory Services Network's Avenue Therapeutics position peaked at $88K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.